ZDHHC11 and ZDHHC11B are critical novel components of the oncogenic MYC-miR-150-MYB network in Burkitt lymphoma
- 23 March 2017
- journal article
- Published by Springer Nature in Leukemia
- Vol. 31 (6) , 1470-1473
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The role of miR-150 in normal and malignant hematopoiesisOncogene, 2013
- Burkitt's lymphomaThe Lancet, 2012
- Human DHHC proteins: A spotlight on the hidden player of palmitoylationEuropean Journal of Cell Biology, 2012
- A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?Cell, 2011
- Kinetic profiling of the c-Myc transcriptome and bioinformatic analysis of repressed gene promotersCell Cycle, 2011
- Activation of a novel palmitoyltransferase ZDHHC14 in acute biphenotypic leukemia and subsets of acute myeloid leukemiaLeukemia, 2010
- MiRNA profiling in B non‐Hodgkin lymphoma: a MYC‐related miRNA profile characterizes Burkitt lymphomaBritish Journal of Haematology, 2010
- The Cell Cycle and Myc Intersect with Mechanisms that Regulate Pluripotency and ReprogrammingCell Stem Cell, 2009
- Widespread microRNA repression by Myc contributes to tumorigenesisNature Genetics, 2007
- MiR-150 Controls B Cell Differentiation by Targeting the Transcription Factor c-MybCell, 2007